Status:
COMPLETED
Supporting Tailored And Responsive PrEP in Rural North Carolina
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Pre-Exposure Prophylaxis
Eligibility:
All Genders
18-39 years
Phase:
NA
Brief Summary
This project consists of two phases to be completed over five years. Phase 1 (Aims 1 and 2) will be completed during Years 1-3 (R61). The Phase 1 study is a randomized trial of a multilevel HIV Pre-Ex...
Detailed Description
Participants will be randomized 1:1 to an intervention or control condition. Participants enrolled in the intervention arm will receive a multilevel intervention with three components: a PrEP Navigato...
Eligibility Criteria
Inclusion
- Report sexual activity with a male in the past 12 months
- Received HIV testing within 90 days pre-enrollment and not known to be HIV-positive at screening/enrollment by self-report
- Age 18-39 years
- Have daily smartphone access
- Be English speaking
- Deny current PrEP use
Exclusion
- Confirmed prior HIV-positive diagnosis
- Prior PrEP use (oral PrEP or injectable PrEP) within the last 3 months.
Key Trial Info
Start Date :
August 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2025
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT05984030
Start Date
August 31 2023
End Date
June 1 2025
Last Update
August 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27514